A great find and a very educational article about Mass General’s Healey center (history and modus operandi operations). Dr MT really putting it out there. MPL certainly would benefit from acceptance by Healey as a new arm to evaluate the efficacy of MPL...no lack of patients it would seem and the funding possibilities would be enormous let alone the publicity should MPL prove effective against MND.
Click the link t read: https://www.pharmavoice.com/news/healey-als-drug-platform-trial-cudkowicz-mass-general/703115/
Ann: PAA completes Phase 1 and files for Orphan Drug Designation, page-135
-
- There are more pages in this discussion • 296 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $99.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $66.86K | 327.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27750 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 84999 | 3 |
View Market Depth
| Last trade - 14.42pm 27/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |